Pharmacokinetics and pharmacodynamics of cisplatin after intra-operative Hyperthermic intraperitoneal chemoperfusion (HIPEC)ZEAMARI, S; FLOOT, B; VAN DER VANGE, N et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1643-1648, issn 0250-7005, 6 p.Article

Relation between intracellular accumulation and cytotoxic activity of cis-[((1R, 2R)-1,2-cyclohexanediamine-N, N')bis(myristato)]platinum(II) suspended in lipiodolKISHIMOTO, Shuichi; OHTANI, Aya; FUKUDA, Hisayuki et al.Biological & pharmaceutical bulletin. 2003, Vol 26, Num 5, pp 683-686, issn 0918-6158, 4 p.Article

Cisplatin-induced cytotoxicity is blocked by brain-derived neurotrophic factor activation of TrkB signal transduction path in neuroblastomaJABOIN, Jerry; HONG, Audrey; CHONG JAI KIM et al.Cancer letters. 2003, Vol 193, Num 1, pp 109-114, issn 0304-3835, 6 p.Article

Up-regulation of MDR1 function and expression by cisplatin in LLC-PK₁ cellsTAKARA, Kohji; TSUJIMOTO, Masayuki; KOKUFU, Misato et al.Biological & pharmaceutical bulletin. 2003, Vol 26, Num 2, pp 205-209, issn 0918-6158, 5 p.Article

Induction of Thymidine phosphorylase expression by Taxol does not enhance Furtulon sensitivity in a cisplatin-resistant human ovarian carcinoma Cell lineHATA, Kohkichi; OSAKI, Mitsuhiko; KANASAKI, Haruhiko et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1525-1531, issn 0250-7005, 7 p.Article

Role of the p38 MAPK pathway in cisplatin-based therapyHERNANDEZ LOSA, Javier; PARADA COBO, Carlos; GUINEA VINIEGRA, Juan et al.Oncogene (Basingstoke). 2003, Vol 22, Num 26, pp 3998-4006, issn 0950-9232, 9 p.Article

Traitement de 1^re ligne = First line treatmentBUNEL, V; BERGHMANS, T.Revue des maladies respiratoires actualités (Print). 2014, Vol 6, Num 2, pp 121-125, issn 1877-1203, 5 p.Article

Effect of Curcumin on Inflammation and Oxidative Stress in Cisplatin-lnduced Experimental NephrotoxicityKUHAD, Anurag; PILKHWAL, Sangeeta; SHARMA, Sameer et al.Journal of agricultural and food chemistry (Print). 2007, Vol 55, Num 25, pp 10150-10155, issn 0021-8561, 6 p.Article

Cisplatin: mode of cytotoxic action and molecular basis of resistanceSIDDIK, Zahid H.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7265-7279, issn 0950-9232, 15 p.Article

ATM-dependent nuclear accumulation of IKK-α plays an important role in the regulation of p73-mediated apoptosis in response to cisplatinYOSHIDA, K; OZAKI, T; FURUYA, K et al.Oncogene (Basingstoke). 2008, Vol 27, Num 8, pp 1183-1188, issn 0950-9232, 6 p.Article

Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatinNAKAYAMA, Kentaro; TAKEBAYASHI, Yuji; NAKAYAMA, Satoru et al.Cancer letters. 2003, Vol 192, Num 2, pp 227-235, issn 0304-3835, 9 p.Article

Sequence variations of mitochondrial DNA and individual sensitivity to the ototoxic effect of cisplatinPETERS, Ulrike; PREISLER-ADAMS, S; LANVERS-KAMINSKY, Claudia et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1249-1255, issn 0250-7005, 7 p.Article

Cell response of Escherichia coli to cisplatin-induced stressSTEFANOPOULOU, Maria; KOKOSCHKA, Malte; SHELDRICK, William S et al.Proteomics (Weinheim. Print). 2011, Vol 11, Num 21, pp 4174-4188, issn 1615-9853, 15 p.Article

Increased Glutathione Level Is not Involved in Enhanced Bleomycin Sensitivity in Cisplatin-resistant 2780^CP CellsTANAKA, Toshiko; KUROKAWA, Hideo; MATSUNO, Koji et al.Anticancer research. 2008, Vol 28, Num 5A, pp 2663-2668, issn 0250-7005, 6 p.Article

Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemiaVANNOZZI, Maria O; OTTONE, Massimo; MARIGGIO, Maria A et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1509-1516, issn 0250-7005, 8 p.Article

Incision of a 1,3-intrastrand d(GpTpG)-cisplatin adduct by nucleotide excision repair proteins from yeastKONG, Stephanie E; SVEJSTRUP, Jesper Q.DNA repair. 2002, Vol 1, Num 9, pp 731-741, issn 1568-7864, 11 p.Article

Functional consequences of PRPF39 on distant genes and cisplatin sensitivitySTARK, Amy L; DELANEY, Shannon M; WHEELER, Heather E et al.Human molecular genetics (Print). 2012, Vol 21, Num 19, pp 4348-4355, issn 0964-6906, 8 p.Article

Action of metyrapone and tetracosactrin to modify cisplatin-induced acute and delayed emesis in the ferretSAM, Tasia S. W; KAN, Kelvin K. W; NGAN, Man P et al.European journal of pharmacology. 2003, Vol 466, Num 1-2, pp 163-168, issn 0014-2999, 6 p.Article

Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancyKOREN, Claude; YERUSHALMI, Rinat; KATZ, Alan et al.American journal of clinical oncology. 2002, Vol 25, Num 6, pp 625-626, issn 0277-3732, 2 p.Article

Inhibition of cisplatin-induced ATR activity and enhanced sensitivity to cisplatinYAZLOVITSKAYA, Eugenia M; PERSONS, Diane L.Anticancer research. 2003, Vol 23, Num 3B, pp 2275-2279, issn 0250-7005, 5 p.Article

Molecular mechanisms of hyperthermia- and cisplatin-induced cytotoxicity in T cell leukemiaMAUZ-KORHOLZ, C; DIETZSCH, S; SCHIPPEL, P et al.Anticancer research. 2003, Vol 23, Num 3B, pp 2643-2647, issn 0250-7005, 5 p.Article

Comparative study between the interaction of dephosphorylated amifostine (WR-1065) and amoxicilline with pBR322 in absence and presence of cisplatin by AFMAMAT, E; PRIETO, M. J; MORENO, V et al.International journal of pharmaceutics. 2004, Vol 270, Num 1-2, pp 75-82, issn 0378-5173, 8 p.Article

Neuroprotective effects of Kv7 channel agonist, retigabine, for cisplatin-induced peripheral neuropathyNODERA, Hiroyuki; SPIEKER, Andrew; SUNG, Minhee et al.Neuroscience letters. 2011, Vol 505, Num 3, pp 223-227, issn 0304-3940, 5 p.Article

Cervical radiculopathy due to intra-arterial infusion of cisplatinNISHIMURA, Toshiro; SANADA, Jun-Ichiro; FURUKAWA, Mitsuru et al.Journal of laryngology and otology. 2005, Vol 119, Num 8, pp 649-650, issn 0022-2151, 2 p.Article

Low renal toxicity of Lipoplatin compared to cisplatin in animalsDEVARAJAN, Prasad; TARABISHI, Ridwan; MISHRA, Jaya et al.Anticancer research. 2004, Vol 24, Num 4, pp 2193-2200, issn 0250-7005, 8 p.Article